Eden Research Share Discussion Threads

[supersonico] 13/7/2018 21:39

I won't be worrying about volatility when this rolls past 50p on the way to £1 after Ed Hugo and Prof Alice Roberts give us a good send off:)

[northwick] 13/7/2018 21:39

Let's hope the share price does not drop now that Sean Smith has purchased some 98k shares today. We all are still suffering from his last purchase

[supersonico] 13/7/2018 21:38

Infobot 4

Carte du 12 au 18 Juillet 2018

Risque Botrytis

[investingisatrickygame] 13/7/2018 21:26

Late arrivals sniffing a buck will make it more volatile in my opinion. Bring them in now and educate them for a more stable share peice

[supersonico] 13/7/2018 21:04

I'm perfectly happy that 'The non-invested' are not here atm as they would have only got in the way and been really annoying with their over excited gibberish and pushed the price up before I had accumulated enough to buy a small Scotish island when Eden do finally announce their big news.

It won't be long before the herd arrive asking us to summarise 5+ years of research into 10 short words because Eden made it on to the LSE top risers chart.

[investingisatrickygame] 13/7/2018 19:30

Super,

I agree, but again that only addresses existing shareholders. It doesn't explain why the non-invested don't know about Eden and they should

[supersonico] 13/7/2018 17:41

We all know why know one reacts to the Directors buying.. it's because for 5 years they have told us in the coming months incongruences about the Bayer and TT.. NDA Duckies they are now lining up in short order.

The wolf has run out of tears.

[investingisatrickygame] 13/7/2018 16:49

They can explain the Company and the opportunity in full, in layman's terms. With the exception of those committed individuals e.g. AGM attendees, few others are taking notice.

If more took notice and were equally enthused as management and us, our share price might be 20p+. This would be a much better launch pad for when significant new comes.

The uninvested will not see these buys or be looking for them. As such, they can't react and nor can the price.

[attyg] 13/7/2018 16:35

Sad how despite these director buys we still see someone selling.
Not sure what else the executive can do.
I'm a believer.
And so are the executive.

[investingisatrickygame] 13/7/2018 12:33

Glyphosate, if anyone is interested

hxxps://www.politico.eu/article/glyphosate-carcinogenic-debate-christoper-portier-the-man-europes-food-watchdog-fears-the-most/

[attyg] 11/7/2018 16:20

Like I said, I'm not into branding.

If we ever get to being known as sustain (with out without and E) inside I'll be too drunk to know.

[supersonico] 11/7/2018 16:09

Makes sense..

[investingisatrickygame] 11/7/2018 15:54

Actually, ' Sustaine' :)

[attyg] 11/7/2018 15:48

Basically changed to sustain

I'm not into the branding bit as you can see

[supersonico] 11/7/2018 15:38

Investing,

No not being sarcastic.. more likely being stupid or having another dur-blond moment:)

Where is GO-E mentioned in the Preliminary report?

Where is GO-E mentioned in the May 2018 presentation.

When was the last time EDEN referred to G0-E

[investingisatrickygame] 11/7/2018 15:23

Super,

I'm confused unless you're being sarcastic?

[supersonico] 11/7/2018 13:58

Anyone seen GO-E lately ?

Am I just not seeing it ? or maybe the Ducks ate it.

TT won't be happy if we've gone and lost it.

Perhaps Tony Peters will put me straight.

Specsavers??

[investingisatrickygame] 11/7/2018 12:58

Super,

It's simple, isn't it. When long-term investors such as yourself don't know, then the full story needs telling. There is so much to explain that can easily be done aside of NDA's.

Eden just needs to get the investment community to understand the investment proposition, then the share price might shift gears.

[brucie5] 11/7/2018 12:54

Monsanto in the news. Can now be sued for cacinogenic properties of Roundup in the U.S.

[supersonico] 11/7/2018 12:24

Questions I still have;

Was Bayer in 2013/4 interested in any other Eden IP beyond companion animals?

Why no incremental payments from Bayer post Teva?

Who will be our strategic/licence partner for the unallocated Pipeline products?

[investingisatrickygame] 11/7/2018 11:45

I imagine at the end of the day that Bayer or ANO will ultimately be buying the IP and it is this that will determine the value of Eden (in the event of a sale OR rights in perpetuity to a sector or specific product line e.g. Mevalone)

I'm certain that the measure of value will be something like

Current/Forecast market value per annum, x number of years to develop x anticipated market share + cost to develop VERSUS cost to buy Eden/Product line (s)

OR

Forecast income on existing line(s) per annum x number of years for existing patent(s) VERSUS cost to buy Eden/Product line(s)

The loss of income for off patent lines or/and being out of a new market because of the time to R and D the same when someone else already has an/the answer is inconceivable in my opinion so Eden is a definite and possible buy target for one of them.

I see the strong possibility of Eden being sold in part or whole and Eden becoming and in-house or independent R and D business, but with first right of purchase on new developments going to the original buyer for a pre-determined time. In the independent scenario, Eden could still be a listed company from which shareholders could reap benefits again and at a future date.

[supersonico] 11/7/2018 09:28

Yes, I accept this all could be a very wise IP protection dance that Eden have been coordinating and 'in short order' we'll see the show.

Please be seated..Madam

[attyg] 11/7/2018 08:26

Interesting programme last night on BBC 4 The rise and fall of Nokia.

One point that hit home was when a lady spoke of how vital the IP was in defending their products against Motorola etc.

It is good to know we have plenty IP and plenty muscle protecting this IP.

[attyg] 11/7/2018 07:59

Couldn't agree more.

I do, however, believe that TT will deliver this year.